That's important, due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be efficient. Simply put, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (angel investor). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're designed to do. This was a breakthrough practically no one noticed. But it's going to have profound implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of financial investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (bleeding edge). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back perhaps significantly prior to going higher - jeff brown prediction. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. However that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown biotech genome sequencing. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of terrific personal companies on the verge of hitting the public markets And I've been dealing with a brand-new way for you to invest even prior to these business go public.
This chance has been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to reserve your spot free of charge.
Emma Walsh here, managing editor of the Diary. Routine Journal readers know that tech isn't our typical beat (jeff brown biotech stocks). And when it pertains to tech investing, we leave it to the professionals. The good news is, we have a number of such professionals in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing specialists we understand (brownstone research stock). In reality, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge picture and forecast what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing rapid growth and producing extraordinary chances for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. longtime readers. But despite what lots of readers may think, this is a pattern that's just getting begun. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled devices were still sold.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown genetic sequencer stock). Losing 2 months of production and sales truly affects how lots of 5G devices are sold in the fiscal year. When you think about all of that, offering 250 million units is amazing. More notably, the delays triggered by the pandemic developed a lots of suppressed demand. And that demand is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G devices will be shipped in 2021 - second wave. Which's not my only 5G prediction When I have actually discussed 5G in the past, I've explained its 3 various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Stage Three, 5G services start to be used (jeff brown 2021 predictions). That's when we start to see applications running on 5G networks. Think about things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage 3 by this summer season. This starts something of a virtuous cycle: Many people don't actually care about the innovation. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open a suite of extraordinary applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The investment opportunities moving forward will be massive. Stepping far from 5G, the next crucial innovation I foresee in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software.
The program can crash or not function properly. CRISPR uses a comparable concept but with our hereditary code. "Typos" in our genome can lead to illness. CRISPR can correct these "typos." For years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And during that time, there were actually just three companies operating in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire market is efficiently a greenfield chance.
There's space for numerous business to exist in this area. jeff brown top stock pick 2021. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or three more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can properly anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error procedure. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're created to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however a number of drug therapies produced using this innovation. This was one of those breakthroughs that nearly nobody discovered. But it's going to have extensive implications for treating illness. And, of course, there will be a lot of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back possibly considerably prior to going greater. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin - last week. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that preliminary suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. artificial intelligence. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the information is up to date as of February 2021, but we could not individually validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like ability to select winning innovation stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an exceptional perspective on the marketplace. He's always on the hunt for brand-new chances, and he shares much of his finest picks in the Future Report.
That's high praise, however it's not absurdly reasoned. Brown has an outstanding track record as a stock-picker, and he effectively predicted some of the biggest economic events of the past 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it right whenever, however Jeff Brown's accurate forecasts have earned him legions of devoted fans. That says a lot about his capability. The Near Future Report is published by Brownstone Research, a prominent financial research study publisher. Brownstone Research study uses a number of research study services with a variety of specializations - jeff brown stock predictions.
The company is also associated with Bonner & Partners, another well-respected research study publisher - jeff brown prediction. On its website, Brownstone states its mission is to provide retail investors with professional-grade research: "For too long, the very best investment research study has actually not been readily available to private investors. It has been typically reserved for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown stock predictions 2021. The objective of Brownstone Research is to make that sort of exclusive research study available to any investors seeking to acquire an edge in the markets. The objective is easy to deliver distinct and rewarding investment research discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the company's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After years of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you know even a bit about the market, you understand that he has a credibility as a King Midas of sorts. jeff brown biotech picks. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. jeff brown biotech stocks. might be "the most significant trend of the 2020s, and he's not alone. Examine out these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying 2 cutting-edge technologies: expert system and electric vehicles. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing except the automobile industry's Holy Grail. As you understand, electrical lorries and self-driving cars and truck stocks have actually been big this year, however the Wall Street machine has been big on buzz without much concrete outcome. Regardless of an extreme boost in competition over the past couple of years, Brown still thinks Musk has the very best chance of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Car, and it might be the future of transportation. Essentially, this innovation would enable you to lease your cars and truck as a self-governing, self-driving taxi when you're not utilizing it. You just leave the car and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a substantial portion of the revenues. It sounds insane, however it might be closed than you believe.